Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Femoral Arteriotomy Closure
Interventions
DEVICE

MANTA Vascular Closure Device

The MANTA® Vascular Closure Device consists of a 14F or 18F MANTA® Closure Device, a 14F or 18F Sheath with Introducer, and an 8F Depth Locator. In the U.S. and Canada, the MANTA® Vascular Closure Device is indicated for closure of femoral arterial access sites while reducing time to hemostasis following the use of 10-20F devices or sheaths (12-25F OD) in endovascular catheterization procedures.

Trial Locations (10)

10029

RECRUITING

Mount Sinai Hospital, New York

10467

NOT_YET_RECRUITING

Montefiore Medical Center, New York

11030

RECRUITING

North Shore University Hospital, Manhasset

14203

RECRUITING

University at Buffalo, Buffalo

32207

RECRUITING

Baptist Health Medical Center-Jacksonville, Jacksonville

32806

RECRUITING

Orlando Health, Inc, Orlando

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

48202

RECRUITING

Henry Ford Health, Detroit

78665

RECRUITING

Baylor Scott & White - Round Rock, Round Rock

H1T 1C8

RECRUITING

Montreal Heart Institute, Montreal

Sponsors
All Listed Sponsors
collaborator

Vascular Solutions LLC

INDUSTRY

collaborator

Teleflex Medical Inc

UNKNOWN

lead

Essential Medical, Inc.

INDUSTRY

NCT05936996 - Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes | Biotech Hunter | Biotech Hunter